Clinical Trial Update: Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating whether using circulating tumor cells to guide first-line treatment for metastatic, hormone-receptor-positive breast cancer has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer
• Infiltrating Ductal Carcinoma of the Breast

Snippet

Sponsor: Institut Curie | Conditions: Ductal Infiltrating Metastatic Breast Cancer, Hormone-receptors Positive Breast Cancer | Phase 3 | Status: UNKNOWN